Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial

INTRODUCTION: Despite being one of the first diseases to be genetically characterised, β-thalassaemia remains a disorder without a cure in a majority of patients. Most patients with β-thalassaemia receive only supportive treatment and therefore have a poor quality of life and shorter life spans. Hyd...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasara, Nirmani, Wickramarathne, Nethmi, Mettananda, Chamila, Manamperi, Aresha, Premawardhena, Anuja, Mettananda, Sachith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592299/
https://www.ncbi.nlm.nih.gov/pubmed/33109679
http://dx.doi.org/10.1136/bmjopen-2020-041958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592299/
https://www.ncbi.nlm.nih.gov/pubmed/33109679
http://dx.doi.org/10.1136/bmjopen-2020-041958

Ejemplares similares